arginine has been researched along with Branch Vein Occlusion in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Binder, H; Closs, EI; Gericke, A; Habermeier, A; Pfeiffer, N; Ponto, KA; Rosner, AK; Scharrer, I | 1 |
| Mangioris, G; Mendrinos, E; Papadopoulou, DN; Petropoulos, IK; Pournaras, CJ | 1 |
| Carru, C; Carta, F; Deiana, L; Gaspa, L; Pinna, A; Sotgia, S; Usai, MF; Zinellu, A; Zinellu, E | 1 |
| Donati, G; Pournaras, CJ; Tsacopoulos, M | 1 |
4 other study(ies) available for arginine and Branch Vein Occlusion
| Article | Year |
|---|---|
[Asymmetric dimethylarginine (ADMA) in retinal vein occlusion-Results from the Gutenberg RVO study].
Topics: Aged; Arginine; Humans; Hypertension; Retinal Vein Occlusion; Risk Factors | 2021 |
Intravitreal l-Arginine injection reverses the retinal arteriolar vasoconstriction that occurs after experimental acute branch retinal vein occlusion.
Topics: Animals; Arginine; Arterioles; Blood Pressure; Disease Models, Animal; Injections; Microinjections; Retinal Artery; Retinal Vein Occlusion; Swine; Swine, Miniature; Vasoconstriction; Vasodilation; Vasodilator Agents; Vitreous Body | 2010 |
Increased plasma asymmetric dimethylarginine (ADMA) levels in retinal venous occlusive disease.
Topics: Aged; Arginine; Case-Control Studies; Cohort Studies; Cysteine; Female; Humans; Male; Middle Aged; Retinal Vein Occlusion; Risk Factors | 2008 |
Effect of nitroprusside on arteriolar constriction after retinal branch vein occlusion.
Topics: Animals; Arginine; Constriction, Pathologic; Nitric Oxide; Nitroprusside; Regional Blood Flow; Retinal Artery; Retinal Vein Occlusion; Swine; Swine, Miniature; Vasoconstriction; Vasodilation; Vasodilator Agents | 1998 |